Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004-BHS IV.

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Guidelines for management of hypertension: report of the third working party of the British Hypertension Society

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Selected major risk factors and global and regional burden of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Impact of high-normal blood pressure on the risk of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Study on COgnition and Prognosis in the Elderly (SCOPE).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists' Collaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Cardiovascular protection and blood pressure reduction: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

The Effect of Nisoldipine as Compared with Enalapril on Cardiovascular Outcomes in Patients with Non-Insulin-Dependent Diabetes and Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Effects of Calcium-Channel Blockade in Older Patients with Diabetes and Systolic Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Comparison of antihypertensive treatments in preventing cardiovascular events in elderly diabetic patients: results from the Swedish Trial in Old Patients with Hypertension-2. STOP Hypertension-2 Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Reduced cardiovascular morbidity and mortality in hypertensive diabetic patients on first-line therapy with an ACE inhibitor compared with a diuretic/beta-blocker-based treatment regimen: a subanalysis of the Captopril Prevention Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

The role of exercise training in the treatment of hypertension: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Effects of alcohol reduction on blood pressure: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

The influence of dietary and nondietary calcium supplementation on blood pressure: an updated metaanalysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

The effect of chronic coffee drinking on blood pressure: a meta-analysis of controlled clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Hypertension treatment and control in five European countries, Canada, and the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Better blood pressure control: how to combine drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Survival in treated hypertension: follow up study after two decades

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre ra

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

North of England evidence based guideline development project: guideline on the use of aspirin as secondary prophylaxis for vascular disease in primary care. North of England Aspirin Guideline Development Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Home blood pressure monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Blood pressure measuring devices: recommendations of the European Society of Hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Use and interpretation of ambulatory blood pressure monitoring: recommendations of the British hypertension society

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Prognostic value of ambulatory blood-pressure recordings in patients with treated hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Prediction of stroke by ambulatory blood pressure monitoring versus screening blood pressure measurements in a general population: the Ohasama study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Predicting Cardiovascular Risk Using Conventional vs Ambulatory Blood Pressure in Older Patients With Systolic Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Clinic, home and ambulatory pulse pressure: comparison and reproducibility.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Cardiovascular outcome in white-coat versus sustained mild hypertension: a 10-year follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Working Group on Blood Pressure Monitoring of the European Society of Hypertension International Protocol for validation of blood pressure measuring devices in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

An updated coronary risk profile. A statement for health professionals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Predictive accuracy of the Framingham coronary risk score in British men: prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Comparison of cardiovascular risk between patients with type 2 diabetes and those who had had a myocardial infarction: cross sectional and cohort studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

VALUE trial: Long-term blood pressure trends in 13,449 patients with hypertension and high cardiovascular risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Primary prevention of hypertension: clinical and public health advisory from The National High Blood Pressure Education Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Long-term effects of weight loss and dietary sodium reduction on incidence of hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

National Heart, Lung, and Blood Institute Workshop on Sodium and Blood Pressure : a critical review of current scientific evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Progressive resistance exercise and resting blood pressure : A meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Effect of aerobic exercise on blood pressure: a meta-analysis of randomized, controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

A randomized trial of improved weight loss with a prepared meal plan in overweight and obese patients: impact on cardiovascular risk reduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Effects of dietary patterns on blood pressure: subgroup analysis of the Dietary Approaches to Stop Hypertension (DASH) randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Insulin resistance: the shape of things to come.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Influence of weight reduction on blood pressure: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of nonpharmacologic interventions in the elderly (TONE). TONE Collaborative Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Systematic review of long term effects of advice to reduce dietary salt in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Effect of reduced dietary sodium on blood pressure: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Alcohol consumption and mortality from all causes, coronary heart disease, and stroke: results from a prospective cohort study of scottish men with 21 years of follow up

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

U-shaped relation for alcohol consumption and health in early adulthood and implications for mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Alcohol consumption and mortality among middle-aged and elderly U.S. adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Effects of regular exercise on blood pressure and left ventricular hypertrophy in African-American men with severe hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Exercise and weight loss reduce blood pressure in men and women with mild hypertension: effects on cardiovascular, metabolic, and hemodynamic functioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Comparison of single versus multiple lifestyle interventions: are the antihypertensive effects of exercise training and diet-induced weight loss additive?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Systematic review of randomised controlled trials of multiple risk factor interventions for preventing coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Relation of Leisure-Time Physical Activity and Cardiorespiratory Fitness to the Risk of Acute Myocardial Infarction in Men

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Exercise in leisure time: coronary attack and death rates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Effects of oral potassium on blood pressure. Meta-analysis of randomized controlled clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Reduction in blood pressure with a low sodium, high potassium, high magnesium salt in older subjects with mild to moderate hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Effect of stress management on blood pressure in mild primary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Treating hypertension with a device that slows and regularises breathing: a randomised, double-blind controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

How smoking affects blood pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Association between smoking and blood pressure: evidence from the health survey for England

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Mortality in relation to smoking: 40 years' observations on male British doctors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Long term effect on mortality of stopping smoking after unstable angina and myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

How soon after quitting smoking does risk of heart attack decline?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

An Analysis of the Effectiveness of Interventions Intended to Help People Stop Smoking

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Smoking cessation: evidence based recommendations for the healthcare system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Systematic review of dietary intervention trials to lower blood total cholesterol in free-living subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Effects of dietary fish and weight reduction on ambulatory blood pressure in overweight hypertensives

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Department of veterans Affairs single-drug therapy of hypertension study. Revised figures and new data. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Workshop: mechanisms and cardiovascular damage in hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

A comparison of outcomes with angiotensin-converting--enzyme inhibitors and diuretics for hypertension in the elderly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus. Atherosclerosis Risk in Communities Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Matching the right drug to the right patient in essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Why is plasma renin activity lower in populations of African origin?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

The management of hypertensive disease in black patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Importance of the renin system in determining blood pressure fall with salt restriction in black and white hypertensives

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Double-blind, placebo-controlled crossover comparison of five classes of antihypertensive drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Rationale, design, methods and baseline demography of participants of the Anglo-Scandinavian Cardiac Outcomes Trial. ASCOT investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Risk of new-onset diabetes in the Losartan Intervention For Endpoint reduction in hypertension study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Resistant hypertension: comparing hemodynamic management to specialist care.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Raised aldosterone to renin ratio predicts antihypertensive efficacy of spironolactone: a prospective cohort follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

A meta-analysis of outcome trials in elderly hypertensives

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

HMG-CoA reductase inhibitor therapy and stroke risk reduction: an analysis of clinical trials data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Treatment with atorvastatin to the National Cholesterol Educational Program goal versus 'usual' care in secondary coronary heart disease prevention. The GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Antioxidants and Atherosclerotic Heart Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

A strategy to reduce cardiovascular disease by more than 80%

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Effects of losartan on cardiovascular morbidity and mortality in patients with isolated systolic hypertension and left ventricular hypertrophy: a Losartan Intervention for Endpoint Reduction (LIFE) substudy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Antihypertensive drugs in very old people: a subgroup meta-analysis of randomised controlled trials. INDANA Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Hypertension in the Very Elderly Trial (HYVET): protocol for the main trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Secular trends in mortality by stroke subtype in the 20th century: a retrospective analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Variations in case fatality and dependency from stroke in western and central Europe. The European BIOMED Study of Stroke Care Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Long-term survival after first-ever stroke: the Oxfordshire Community Stroke Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Blood pressure in acute stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Very high blood pressure in acute stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Blood pressure and clinical outcomes in the International Stroke Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

The ACCESS Study: evaluation of Acute Candesartan Cilexetil Therapy in Stroke Survivors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Guidelines for the early management of patients with ischemic stroke: A scientific statement from the Stroke Council of the American Stroke Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Blood pressure after stroke. A one-year follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Use of ramipril in preventing stroke: double blind randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Analysis of pooled data from the randomised controlled trials of endarterectomy for symptomatic carotid stenosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Effects of individual risk factors on the incidence of cardiovascular events in the treated hypertensive patients of the Hypertension Optimal Treatment Study. HOT Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

The unique vulnerability of diabetic subjects to hypertensive injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Influence of diabetes and type of hypertension on response to antihypertensive treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Antihypertensive treatment in patients with type-2 diabetes mellitus: what guidance from recent controlled randomized trials?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Effect of losartan on sudden cardiac death in people with diabetes: data from the LIFE study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Pathogenesis, prevention, and treatment of diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Prevention of diabetic renal disease with special reference to microalbuminuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Risk factors for development of incipient and overt diabetic nephropathy in patients with non-insulin dependent diabetes mellitus: prospective, observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Effects of blood pressure level on progression of diabetic nephropathy: results from the RENAAL study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

The Effects of Dietary Protein Restriction and Blood-Pressure Control on the Progression of Chronic Renal Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE): a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Microalbuminuria predicts cardiovascular events and renal insufficiency in patients with essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. The Atherosclerosis Risk in Communities Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Hormone replacement therapy, heart disease, and other considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

A clinical trial of estrogen-replacement therapy after ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Clinical review 162: cardiovascular endocrinology 3: an epidemiologist looks at hormones and heart disease in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Effects of estrogen plus progestin on health-related quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

The hypertensive disorders of pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Treatment of hypertension in pregnant women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Blood-pressure measurement and classification in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Measuring diastolic blood pressure in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Prevention of pre-eclampsia: status and perspectives 2000

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Change in paternity: a risk factor for preeclampsia in multiparas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Primary, secondary, and tertiary prevention of pre-eclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Pathogenesis and genetics of pre-eclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Antiplatelet drugs for prevention of pre-eclampsia and its consequences: systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Vitamin C and E supplementation in women at risk of preeclampsia is associated with changes in indices of oxidative stress and placental function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Final report of study on hypertension during pregnancy: the effects of specific treatment on the growth and development of the children

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Comparative risk-benefit assessment of drugs used in the management of hypertension in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Atenolol in essential hypertension during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Effects of diuretics on plasma volume in pregnancies with long-term hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Hypertension in pregnancy: definitions, familial factor, and remote prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Long term mortality of mothers and fathers after pre-eclampsia: population based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Hypertensive diseases of pregnancy and risk of hypertension and stroke in later life: results from cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Ethnic differences in blood pressure and the prevalence of hypertension in England

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Renal vascular disease in African-Americans and other racial minorities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Ethnic differences in the hypertensive heart and 24-hour blood pressure profile

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Salt sensitivity and resistance of blood pressure. Age and race as factors in physiological responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Management of high blood pressure in African Americans: consensus statement of the Hypertension in African Americans Working Group of the International Society on Hypertension in Blacks

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Westernised Asians and cardiovascular disease: nature or nurture?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Effect of antioxidants on the occurrence of pre-eclampsia in women at increased risk: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Are β-Blockers Efficacious as First-line Therapy for Hypertension in the Elderly?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

Some think him ill-tempered and queer..

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

7 January 2021

Randomised trial of effects of calcium antagonists compared with diuretics and beta-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

7 January 2021

Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

7 January 2021

Calcium-Channel Blockers for Hypertension — Uncertainty Continues

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

7 January 2021

Effects of magnesium supplementation in hypertensive patients: assessment by office, home, and ambulatory blood pressures

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

7 January 2021

Improved hypertension management and control: results from the health survey for England 1998

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

7 January 2021

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

7 January 2021

Prognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24-h blood pressure: the Ohasama study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

7 January 2021

Diagnosis of white coat hypertension by ambulatory blood pressure monitoring

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

7 January 2021

Isolated office hypertension: a prehypertensive state?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

7 January 2021

Is white coat hypertension innocent? Structure and function of the heart in the elderly

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

7 January 2021

2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

7 January 2021

Is the Framingham risk function valid for northern European populations? A comparison of methods for estimating absolute coronary risk in high risk men

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

7 January 2021

Central role of echocardiography in the diagnosis and assessment of heart failure. British Society of Echocardiography.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

7 January 2021

Effects of diet and sodium intake on blood pressure: subgroup analysis of the DASH-sodium trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

7 January 2021

Concomitant risk factors in hypertensives: a survey of risk factors for cardiovascular disease amongst hypertensives in English general practices

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

7 January 2021

The effect of dietary patterns on blood pressure control in hypertensive patients: results from the Dietary Approaches to Stop Hypertension (DASH) trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

7 January 2021

Effects of alcohol and caloric restrictions on blood pressure and serum lipids in overweight men

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

7 January 2021

Randomised controlled trial of a no-added-sodium diet for mild hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

7 January 2021

Evaluation of the effectiveness of a low sodium diet in the treatment of mild to moderate hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

7 January 2021

Effectiveness of advice to reduce alcohol consumption in hypertensive patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

7 January 2021

Alcohol consumption--a risk factor for hemorrhagic and non-hemorrhagic stroke

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

7 January 2021

Moderate- and high-intensity exercise lowers blood pressure in normotensive subjects 60 to 79 years of age

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

7 January 2021

Exercise for hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

7 January 2021

Diet and exercise intervention have favourable effects on blood pressure in mild hypertensives: the Oslo Diet and Exercise Study (ODES)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

7 January 2021

Physical activity and cardiovascular risk factors: effect of advice from an exercise specialist in Australian general practice.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

7 January 2021

Physical fitness as a predictor of mortality among healthy, middle-aged Norwegian men

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

7 January 2021

A meta-analysis of physical activity in the prevention of coronary heart disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

7 January 2021

The association of changes in physical-activity level and other lifestyle characteristics with mortality among men

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

7 January 2021

Effect of calcium supplementation on diastolic blood pressure in young people with mild hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

7 January 2021

Blood pressure response during long-term treatment with magnesium is dependent on magnesium status. A double-blind, placebo-controlled study in essential hypertension and in subjects with high-normal blood pressure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

7 January 2021

Effect of calcium carbonate on blood pressure in normotensive and hypertensive people

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

7 January 2021

Combinations of potassium, calcium, and magnesium supplements in hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

7 January 2021

Controlled trial of long term oral potassium supplements in patients with mild hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

7 January 2021

Double-blind, placebo-controlled trial of potassium chloride in the treatment of mild hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

7 January 2021

Reduction of blood pressure with oral magnesium supplementation in women with mild to moderate hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

7 January 2021

Controlled trial of biofeedback-aided behavioural methods in reducing mild hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

7 January 2021

Smoking cessation and time course of decreased risks of coronary heart disease in middle-aged women

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

7 January 2021

Combined modality therapy of cancer. What is it and when does it work?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

7 January 2021

Meta-analysis on efficacy of nicotine replacement therapies in smoking cessation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

7 January 2021

Optimisation of antihypertensive treatment by crossover rotation of four major classes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

7 January 2021

Medical Research Council trial of treatment of hypertension in older adults: principal results. MRC Working Party

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

7 January 2021

Drug treatment of hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

7 January 2021

ALLHAT: a saga of missed opportunities

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

7 January 2021

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

1 reference

7 January 2021

Renin system analysis defines the special value of combination antihypertensive therapy using an antirenin agent (CEI) with a long-acting calcium channel blocker (CCB)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

7 January 2021

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

7 January 2021

Antihypertensive efficacy and side effects of three beta-blockers and a diuretic in elderly hypertensives: a report from the STOP-Hypertension study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

7 January 2021

Factors affecting changes in blood pressure after acute stroke

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

7 January 2021

The prognostic value of admission blood pressure in patients with acute stroke

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

7 January 2021

Effect of blood pressure and diabetes on stroke in progression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

7 January 2021

Hypotensive therapy in stroke survivors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

7 January 2021

Effect of antihypertensive treatment on stroke recurrence. Hypertension-Stroke Cooperative Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

7 January 2021

Trial of secondary prevention with atenolol after transient ischemic attack or nondisabling ischemic stroke. The Dutch TIA Trial Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

7 January 2021

Systolic and diastolic blood pressure control in antihypertensive drug trials

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

7 January 2021

The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

7 January 2021

Initiation and progression of diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

7 January 2021

Lisinopril and albumin excretion in diabetes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

7 January 2021

Achievement and safety of a low blood pressure goal in chronic renal disease. The Modification of Diet in Renal Disease Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

7 January 2021

ACE-inhibitors: panacea for progressive renal disease?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

7 January 2021

Effect of angiotensin-converting enzyme inhibitors on the progression of nondiabetic renal disease: a meta-analysis of randomized trials. Angiotensin-Converting-Enzyme Inhibition and Progressive Renal Disease Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

7 January 2021

Arterial hypertension, microalbuminuria, and risk of ischemic heart disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

7 January 2021

Urinary Albumin Excretion Predicts Cardiovascular and Noncardiovascular Mortality in General Population

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

7 January 2021

Microalbuminuria in essential hypertension: redefining the threshold

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

7 January 2021

Malignant hypertension in women of childbearing age and its relation to the contraceptive pill

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

7 January 2021

Hormonal contraception and risk of cardiovascular disease. An international perspective

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

7 January 2021

Blood pressure in women using oral contraceptives

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

7 January 2021

A prospective controlled study of the effect on blood pressure of contraceptive preparations containing different types and dosages of progestogen

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

7 January 2021

Summary of the NHLBI Working Group on Research on Hypertension During Pregnancy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

7 January 2021

Validation of the SpaceLabs 90207 ambulatory blood pressure monitor for use in pregnancy.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

7 January 2021

Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension: a meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

7 January 2021

Association of pregnancy-induced-hypertension, pre-eclampsia, and eclampsia with duration of sexual cohabitation before conception

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

7 January 2021

Pre-eclampsia, antiretroviral therapy, and immune reconstitution

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

7 January 2021

Low-Dose Aspirin to Prevent Preeclampsia in Women at High Risk

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

7 January 2021

Antihypertensive drugs in pregnancy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

7 January 2021

Atenolol and fetal growth in pregnancies complicated by hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

7 January 2021

Overview of randomised trials of diuretics in pregnancy.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

7 January 2021

Pregnancy complications and maternal risk of ischaemic heart disease: a retrospective cohort study of 129 290 births

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

7 January 2021

Blood pressure levels and hypertension status among ethnic groups in England

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001683

7 January 2021